Conditions: Acute Myeloid Leukemia; Myelodysplastic Syndromes; Myeloproliferative Neoplasms; Chronic Myelomonocytic Leukemia; Myelofibrosis
Interventions: Drug: Ipilimumab; Biological: CD25hi Treg depleted DLI
Sponsor: Dana-Farber Cancer Institute
Recruiting